[16] [17] Semaglutide (as Wegovy) is further indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with obesity (initial BMI 30 kg/m 2 ) or who are overweight (initial BMI 27 kg/m 2 ) and have at least one weight-related comorbidity such as dysglycemia (prediabetes or type 2 diabetes), hypertension, dyslipidemia, or cardiovascular disease
WHERE TO CONNECT WITH ME: Follow Brandon on IG: Email: [email protected] For Info on Brandons Coaching Services: Brandons Website: My Reading Recommendations: THE MUSCLE & STRENGTH PYRAMIDS The Central Governor Model of Exercise Regulation: LEAN BUILDING VERSUS BULKING PHASES: HOW TO GAIN MUSCLE WITHOUT GETTING FAT | LEAN GAINS SERIES PART 3 | EP
These attributes can help support satiety, weight management efforts or overall wellness, depending on a consumers situation
This process is especially crucial in today's environment, where exposure to environmental toxins is increasingly common, from industrial chemicals to pesticides found in food
Macrophage glucose-6-phosphate dehydrogenase stimulates proinflammatory responses with oxidative stress
If yes: 88% coverage probability for diabetes-indication GLP-1 (Ozempic, Mounjaro) If no: proceed to question 4 Question 4: Is your BMI 30, or 27 with documented comorbidity